Electra Therapeutics raises USD 183 million in Series C financing, co-led by EQT Life Sciences and Nextech, to fund Phase 2/3 clinical studies for its innovative immune-targeting treatments.
Amount Raised
$183 Million
Round Type
Series C
South San FranciscoManufacturingBiotechnologySustainabilityHealth CareScience And EngineeringMiningInvestors
Description
EQT Life Sciences co-led a USD 183 million Series C financing for Electra Therapeutics, a US biotech firm. The funding will support a global Phase 2/3 clinical study for ELA026, targeting secondary hemophagocytic lymphohistiocytosis (sHLH). New investors Sanofi, HBM Healthcare Investments, and Mubadala Capital joined existing backers in this round. Electra aims to develop precision medicines that effectively treat immune-mediated diseases.
Quick answer
Electra Therapeutics raised $183 Million in a Series C round, dated October 22, 2025. Investors: Nextech, Sanofi, HBM Healthcare Investments, Mubadala Capital and EQT Life Sciences. Electra Therapeutics is based in South San Francisco, California, United States.
- How much did Electra Therapeutics raise?
- Electra Therapeutics raised $183 Million in a Series C round on October 22, 2025.
- Who invested in Electra Therapeutics?
- Nextech, Sanofi, HBM Healthcare Investments, Mubadala Capital and EQT Life Sciences are named as investors in this round.
- What does Electra Therapeutics do?
- Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
- Where is Electra Therapeutics based and how big is it?
- Electra Therapeutics is based in South San Francisco, California, United States. Fundz records about 36 employees.
- Who are the decision-makers at Electra Therapeutics?
- Fundz holds 3 contacts at Electra Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Sustainability and Science And Engineering around the same time
Companies in the same sectors as Electra Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- RedHill Biopharma Ltd raised $4M (Corporate Round) on October 20, 2025.
- Virax Biolabs raised $5M (Post-IPO Equity) on December 3, 2025.
- Xeltis raised $58M (Funding Round) on December 2, 2025.
- Lyric Bio raised $6.6M (Seed) on December 2, 2025.
- Morphocell Technologies raised $50M (Series A) on December 1, 2025.
- SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
Who to call at Electra Therapeutics, and when
A new round usually means Electra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Electra Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Electra Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Electra Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Electra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Electra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.